HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alpha-fetoprotein-producing renal cell carcinoma.

Abstract
Alpha-fetoprotein (AFP) is recognized as a tumor marker of yolk sac tumors, liver cancer and some other cancers of the digestive organs. Renal cell carcinoma (RCC) producing AFP is a rare entity. A case of AFP-producing RCC with solitary bone metastasis, but without liver involvement, is reported. The stain specific to AFP proved the presence of AFP in the cytoplasms of more cells of the renal tumors. Additionally, the other published cases are reviewed. These cases indicate that mesoderm-originating malignant tumors such as RCCs can produce AFP in some situations. So, AFP is probably more universal than believed, although it is generally a popular and useful tumor marker for hepatocellular carcinomas and yolk sac tumors.
AuthorsV Poulakis, U Witzsch, R de Vries, E Becht, H M Altmannsberger, S Störkel
JournalUrologia internationalis (Urol Int) Vol. 67 Issue 2 Pg. 181-3 ( 2001) ISSN: 0042-1138 [Print] Switzerland
PMID11490220 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2001 S. Karger AG, Basel.
Chemical References
  • alpha-Fetoproteins
Topics
  • Adult
  • Carcinoma, Renal Cell (metabolism)
  • Humans
  • Kidney Neoplasms (metabolism)
  • Male
  • alpha-Fetoproteins (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: